Sophia Genetics(SOPH)2023-05-08 16:00Revenue and Profitability - Revenue for Q1 2023 was 10,861 thousand in Q1 2022[5] - Gross profit for the period was 6,710 thousand in the same period last year, reflecting a 44.5% increase[5] - Revenue from the SOPHiA DDM Platform was 10.431 million, indicating a growth of 31.5% year-over-year[36] - Total revenue for the three months ended March 31, 2023, was 10.861 million in the same period of 2022[35] Loss and Financial Performance - Operating loss decreased to 25,021 thousand in Q1 2022, representing a 22.0% improvement[5] - Loss for the period was 25,487 thousand in Q1 2022, indicating a 22.8% reduction[7] - The net loss attributed to shareholders for the three months ended March 31, 2023, was 25.487 million in the same period of 2022[41] - Total comprehensive loss for Q1 2023 was 27,020 thousand in Q1 2022, a decrease of 34.2%[7] Cash Flow and Assets - Cash and cash equivalents at the end of Q1 2023 were 161,305 thousand at the end of 2022[10] - Total assets decreased to 243,838 thousand at the end of 2022[10] - Accounts receivable increased to 6.060 million as of December 31, 2022, reflecting a 26.9% rise[40] - The Company had no borrowings outstanding under its credit facility as of March 31, 2023[43] Shareholder Information - The company reported a basic and diluted loss per share of 0.40 in Q1 2022[5] - The weighted average number of shares in issue increased to 64,242,871 as of March 31, 2023, compared to 63,891,630 in the prior year[41] - The Company held 2,072,700 treasury shares as of March 31, 2023, down from 2,483,000 shares held as of March 31, 2022[30] Compensation and Expenses - Share-based compensation expense totaled 3.471 million in the same period of 2022, indicating a decrease of 30%[44] - Total compensation for key management and non-executive directors decreased to 2,520,000 in Q1 2022, a decline of approximately 3.2%[47] - Share-based compensation expense reduced to 1,900,000 in Q1 2022, representing a decrease of about 9.5%[47] - Salaries and other short-term employee benefits slightly decreased to 553,000 in Q1 2022, a decline of approximately 0.4%[47] - Pension costs increased to 50,000 in Q1 2022, reflecting a growth of 4%[47] - Other compensation rose significantly to 17,000 in Q1 2022, marking an increase of approximately 582.4%[47] Other Information - The Company operates in a single operating segment, with financial performance assessed as such by senior management[34] - There were no material subsequent events reported after the reporting date[48]